Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel Clarke

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
BMJ Open|November 28, 2024
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UKHilary Glen, Amit Bahl, Louisa Fleure, et al.
European Urology Oncology|June 28, 2023
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the "Real World"? A Systematic ReviewJoanna Dodkins, Julie Nossiter, Adrian Cook, et al.
European Urology|August 2, 2017
Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and CompetitionAjay Aggarwal, Daniel Lewis, Susan C Charman, et al.
World Journal of Urology|January 13, 2026
Retroperitoneal lymph node dissection for growing teratoma syndrome in testicular cancer: a systematic review of surgical outcomesAlberto Costa Silva, Afonso Morgado, João Alturas Silva, et al.
British Journal of Cancer|July 22, 2022
Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancerAshwin Sachdeva, Claire A Hart, Kyungmin Kim, et al.
European Urology Oncology|February 21, 2024
Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled TrialsCraig Jones, Struan Gray, Michael Brown, et al.
European Urology|February 13, 2017
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer PatientsGiorgio Gandaglia, Alberto Briganti, Noel Clarke, et al.
Analytical Chemistry|January 21, 2026
Spatial-Spectral Deep Learning for Prostate Cancer Tissue Classification in Infrared SpectroscopyLyra O'Leary, Dougal Ferguson, Claire Hart, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survivalRichard W Griffiths, Eyad Elkord, David E Gilham, et al.
BMC Cancer|March 29, 2014
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cellsJeffrey Cummings, Robert Sloane, Karen Morris, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
BMJ Open|November 28, 2024
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UKHilary Glen, Amit Bahl, Louisa Fleure, et al.
European Urology Oncology|June 28, 2023
Does Research from Clinical Trials in Metastatic Hormone-sensitive Prostate Cancer Treatment Translate into Access to Treatments for Patients in the "Real World"? A Systematic ReviewJoanna Dodkins, Julie Nossiter, Adrian Cook, et al.
European Urology|August 2, 2017
Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and CompetitionAjay Aggarwal, Daniel Lewis, Susan C Charman, et al.
World Journal of Urology|January 13, 2026
Retroperitoneal lymph node dissection for growing teratoma syndrome in testicular cancer: a systematic review of surgical outcomesAlberto Costa Silva, Afonso Morgado, João Alturas Silva, et al.
British Journal of Cancer|July 22, 2022
Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancerAshwin Sachdeva, Claire A Hart, Kyungmin Kim, et al.
European Urology Oncology|February 21, 2024
Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled TrialsCraig Jones, Struan Gray, Michael Brown, et al.
European Urology|February 13, 2017
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer PatientsGiorgio Gandaglia, Alberto Briganti, Noel Clarke, et al.
Analytical Chemistry|January 21, 2026
Spatial-Spectral Deep Learning for Prostate Cancer Tissue Classification in Infrared SpectroscopyLyra O'Leary, Dougal Ferguson, Claire Hart, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survivalRichard W Griffiths, Eyad Elkord, David E Gilham, et al.
BMC Cancer|March 29, 2014
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cellsJeffrey Cummings, Robert Sloane, Karen Morris, et al.
Pageof 9